Evidence map›Paper›PMID 21915354›Full record

ArticlePloS one2011

LEDGF(1-326) decreases P23H and wild type rhodopsin aggregates and P23H rhodopsin mediated cell damage in human retinal pigment epithelial cells.

Rinku Baid, Robert I Scheinman, Toshimichi Shinohara, Dhirendra P Singh, Uday B Kompella

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. The Clinical Relevance of Anti-DFS70 Autoantibodies.Clinical reviews in allergy & immunology · 2017
    Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Rinku BaidDepartment of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America.
Robert I Scheinman
Toshimichi Shinohara
Dhirendra P Singh
Uday B Kompella
University of Colorado Anschutz Medical Campus · USUniversity of Nebraska Medical Center · US

Funding

Gene regulation by LEDGFR01EY013394 · NEI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI SINGH, DHIRENDRA P · 2002 to 2012
$3.0M
Unfolded Protein Response in Lens Epithelial CellsR01EY018172 · NEI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI SHINOHARA, TOSHIMICHI · 2008 to 2012
$1.6M
Development of Small Heat Shock Proteins as Therapeutic Agents in the EyeRC1EY020361 · NEI · UNIVERSITY OF COLORADO DENVER · PI PETRASH, JONATHAN MARK · 2009 to 2010
$992k
Delivery of LEDGF for retinal degenerative disordersR21EY017360 · NEI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI KOMPELLA, UDAY B · 2007 to 2008
$395k
NEI NIH HHS 1 R21EY17360NEI NIH HHS R01 EY013394NEI NIH HHS R01 EY018172NEI NIH HHS R21 EY017360NEI NIH HHS RC1 EY020361NEI NIH HHS RC1EY020361
6 · The paper itself

Abstract

backgroundP23H rhodopsin, a mutant rhodopsin, is known to aggregate and cause retinal degeneration. However, its effects on retinal pigment epithelial (RPE) cells are unknown. The purpose of this study was to determine the effect of P23H rhodopsin in RPE cells and further assess whether LEDGF(1-326), a protein devoid of heat shock elements of LEDGF, a cell survival factor, reduces P23H rhodopsin aggregates and any associated cellular damage.

methodsARPE-19 cells were transiently transfected/cotransfected with pLEDGF(1-326) and/or pWT-Rho (wild type)/pP23H-Rho. Rhodopsin mediated cellular damage and rescue by LEDGF(1-326) was assessed using cell viability, cell proliferation, and confocal microscopy assays. Rhodopsin monomers, oligomers, and their reduction in the presence of LEDGF(1-326) were quantified by western blot analysis. P23H rhodopsin mRNA levels in the presence and absence of LEDGF(1-326) was determined by real time quantitative PCR. PRINCIPAL

findingsP23H rhodopsin reduced RPE cell viability and cell proliferation in a dose dependent manner, and disrupted the nuclear material. LEDGF(1-326) did not alter P23H rhodopsin mRNA levels, reduced its oligomers, and significantly increased RPE cell viability as well as proliferation, while reducing nuclear damage. WT rhodopsin formed oligomers, although to a smaller extent than P23H rhodopsin. Further, LEDGF(1-326) decreased WT rhodopsin aggregates.

conclusionsP23H rhodopsin as well as WT rhodopsin form aggregates in RPE cells and LEDGF(1-326) decreases these aggregates. Further, LEDGF(1-326) reduces the RPE cell damage caused by P23H rhodopsin. LEDGF(1-326) might be useful in treating cellular damage associated with protein aggregation diseases such as retinitis pigmentosa.

Indexed as

Blotting, WesternCell LineCell ProliferationCell SurvivalEpithelial CellsHumansMicroscopy, ConfocalMicroscopy, Phase-ContrastPeptide FragmentsReal-Time Polymerase Chain ReactionRetinal Pigment EpitheliumRhodopsinPeptide FragmentsRhodopsin

Identifiers

PMID21915354
PMCPMC3168525
OpenAlexW2057351494

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.